PRTK
Paratek Pharmaceuticals Inc
Price:  
2.23 
USD
Volume:  
4,755,430.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTK EV/EBITDA

-618.5%
Upside

As of 2025-07-19, the EV/EBITDA ratio of Paratek Pharmaceuticals Inc (PRTK) is -7.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTK's latest enterprise value is 343.47 mil USD. PRTK's TTM EBITDA according to its financial statements is -44.39 mil USD. Dividing these 2 quantities gives us the above PRTK EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.2x - 10.2x 8.0x
Forward P/E multiples 10.7x - 14.2x 12.2x
Fair Price (12.06) - (11.66) (11.56)
Upside -640.9% - -622.9% -618.5%
2.23 USD
Stock Price
(11.56) USD
Fair Price

PRTK EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA